Study aims to enhance colorectal cancer prevention by identifying polyp molecular signals, offering improved sensitivity over at-home DNA tests, which have limited ability to detect precancerous ...
A collaboration between Viome Life Sciences and Scripps Research is set to develop and clinically validate the first ribonucleic acid (RNA) test aimed at detecting precancerous colon polyps. This ...
Hosted on MSN
Microsoft and the microbiome: Viome works with tech giant to optimize AI for molecular health
Viome, a life sciences startup founded by veteran tech entrepreneur Naveen Jain, announced a collaboration with Microsoft to scale its molecular analysis platform — part of what Viome describes as a ...
This article is part of "Build IT: Connectivity," a series about tech powering better business. Viome is aiming to transform disease detection, starting with the gut. The Washington-based biotech ...
First-of-its-kind 1,000-patient clinical study will use RNA-based stool and saliva tests to detect colon polyps — early warning signs of colorectal cancer — before they become cancerous. Study aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback